GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Days Sales Outstanding

Cognetivity Neurosciences (Cognetivity Neurosciences) Days Sales Outstanding : 840.80 (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Days Sales Outstanding?

Cognetivity Neurosciences's average Accounts Receivable for the three months ended in Oct. 2023 was $0.19 Mil. Cognetivity Neurosciences's Revenue for the three months ended in Oct. 2023 was $0.02 Mil. Hence, Cognetivity Neurosciences's Days Sales Outstanding for the three months ended in Oct. 2023 was 840.80.

The historical rank and industry rank for Cognetivity Neurosciences's Days Sales Outstanding or its related term are showing as below:

CGNSF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 748.62   Med: 1423.5   Max: 1423.5
Current: 748.62

During the past 7 years, Cognetivity Neurosciences's highest Days Sales Outstanding was 1423.50. The lowest was 748.62. And the median was 1423.50.

CGNSF's Days Sales Outstanding is ranked worse than
98.75% of 641 companies
in the Healthcare Providers & Services industry
Industry Median: 46.87 vs CGNSF: 748.62

Cognetivity Neurosciences's Days Sales Outstanding increased from Oct. 2022 (0.00) to Oct. 2023 (840.80).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Cognetivity Neurosciences Days Sales Outstanding Historical Data

The historical data trend for Cognetivity Neurosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Days Sales Outstanding Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Days Sales Outstanding
Get a 7-Day Free Trial - - - - 1,454.63

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 281.80 3,208.96 939.88 840.80

Competitive Comparison of Cognetivity Neurosciences's Days Sales Outstanding

For the Health Information Services subindustry, Cognetivity Neurosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Days Sales Outstanding falls into.



Cognetivity Neurosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cognetivity Neurosciences's Days Sales Outstanding for the fiscal year that ended in Jan. 2023 is calculated as

Days Sales Outstanding (A: Jan. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jan. 2022 ) + Accounts Receivable (A: Jan. 2023 )) / count ) / Revenue (A: Jan. 2023 )*Days in Period
=( (0.166 + 0.105) / 2 ) / 0.034*365
=0.1355 / 0.034*365
=1,454.63

Cognetivity Neurosciences's Days Sales Outstanding for the quarter that ended in Oct. 2023 is calculated as:

Days Sales Outstanding (Q: Oct. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2023 ) + Accounts Receivable (A: Oct. 2023 )) / count ) / Revenue (A: Oct. 2023 )*Days in Period
=( (0.203 + 0.184) / 2 ) / 0.021*365 / 4
=0.1935 / 0.021*365 / 4
=840.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Cognetivity Neurosciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019